Deerfield Management Company L.P. Series C Boosts Stake in BioNTech SE - MarketBeat
| 0A3M Stock | USD 110.65 2.27 2.01% |
About 62% of BioNTech's investor base is looking to short. The analysis of the overall investor sentiment regarding BioNTech SE suggests that many traders are alarmed. BioNTech's investing sentiment shows overall attitude of investors towards BioNTech SE.
BioNTech stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of BioNTech daily returns and investor perception about the current price of BioNTech SE as well as its diversification or hedging effects on your existing portfolios.
BioNTech |
Deerfield Management Company L.P. Series C Boosts Stake in BioNTech SE MarketBeat
Read at news.google.com
 |
BioNTech Fundamental Analysis
We analyze BioNTech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BioNTech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BioNTech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Operating Margin
Operating Margin Comparative Analysis
BioNTech is currently under evaluation in operating margin category among its peers. Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
BioNTech SE Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with BioNTech stock to make a market-neutral strategy. Peer analysis of BioNTech could also be used in its relative valuation, which is a method of valuing BioNTech by comparing valuation metrics with similar companies.
Peers
BioNTech Related Equities
| 0GM2 | Leroy Seafood | 2.69 | ||||
| 0K50 | National Beverage | 1.38 | ||||
| 0GW8 | Grieg Seafood | 1.14 | ||||
| ABF | Associated British | 0.85 | ||||
| MONY | Moneysupermarket | 0.05 | ||||
| SUPR | Supermarket Income | 0.14 | ||||
| PFD | Premier Foods | 0.33 |
Check out BioNTech Hype Analysis, BioNTech Correlation and BioNTech Performance. You can also try the CEOs Directory module to screen CEOs from public companies around the world.